Abbott India Ltd banner
A

Abbott India Ltd
NSE:ABBOTINDIA

Watchlist Manager
Abbott India Ltd
NSE:ABBOTINDIA
Watchlist
Price: 26 320 INR -0.28% Market Closed
Market Cap: ₹559.3B

Relative Value

The Relative Value of one ABBOTINDIA stock under the Base Case scenario is hidden INR. Compared to the current market price of 26 320 INR, Abbott India Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABBOTINDIA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

ABBOTINDIA Competitors Multiples
Abbott India Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Abbott India Ltd
NSE:ABBOTINDIA
560.8B INR 8.3 37.1 29.7 30.9
US
Eli Lilly and Co
NYSE:LLY
965.7B USD 14.8 46.8 31.5 33.6
US
Johnson & Johnson
NYSE:JNJ
594B USD 6.3 22.2 15.4 18.9
CH
Roche Holding AG
SIX:ROG
293B CHF 4.8 31.1 13.1 15.3
UK
AstraZeneca PLC
LSE:AZN
237.6B GBP 5.5 31.8 17.5 24.7
CH
Novartis AG
SIX:NOVN
243B CHF 5.5 22.3 13.8 17.7
US
Merck & Co Inc
NYSE:MRK
303.7B USD 4.7 16.6 10.4 12.2
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.2 9.6 11.3
US
Pfizer Inc
NYSE:PFE
152.2B USD 2.4 19.6 7.3 9.8
UK
GSK plc
XETRA:GS71
103.6B EUR 2.8 15.8 8 11.3
P/E Multiple
Earnings Growth PEG
IN
A
Abbott India Ltd
NSE:ABBOTINDIA
Average P/E: 25.6
37.1
15%
2.5
US
Eli Lilly and Co
NYSE:LLY
46.8
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
22.2
7%
3.2
CH
Roche Holding AG
SIX:ROG
31.1
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
31.8
26%
1.2
CH
Novartis AG
SIX:NOVN
22.3
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.6
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
7%
1.9
US
Pfizer Inc
NYSE:PFE
19.6
26%
0.8
UK
GSK plc
XETRA:GS71
15.8
18%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
A
Abbott India Ltd
NSE:ABBOTINDIA
Average EV/EBITDA: 44.5
29.7
16%
1.9
US
Eli Lilly and Co
NYSE:LLY
31.5
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.4
2%
7.7
CH
Roche Holding AG
SIX:ROG
13.1
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
17.5
11%
1.6
CH
Novartis AG
SIX:NOVN
13.8
9%
1.5
US
Merck & Co Inc
NYSE:MRK
10.4
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.6
7%
1.4
US
Pfizer Inc
NYSE:PFE
7.3
-4%
N/A
UK
GSK plc
XETRA:GS71
8
2%
4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
A
Abbott India Ltd
NSE:ABBOTINDIA
Average EV/EBIT: 92.8
30.9
17%
1.8
US
Eli Lilly and Co
NYSE:LLY
33.6
17%
2
US
Johnson & Johnson
NYSE:JNJ
18.9
6%
3.1
CH
Roche Holding AG
SIX:ROG
15.3
6%
2.5
UK
AstraZeneca PLC
LSE:AZN
24.7
24%
1
CH
Novartis AG
SIX:NOVN
17.7
12%
1.5
US
Merck & Co Inc
NYSE:MRK
12.2
6%
2
IE
E
Endo International PLC
LSE:0Y5F
835.4
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
8%
1.4
US
Pfizer Inc
NYSE:PFE
9.8
-1%
N/A
UK
GSK plc
XETRA:GS71
11.3
12%
0.9